VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · IEX Real-Time Price · USD
3.070
+0.110 (3.72%)
At close: Mar 28, 2024, 4:00 PM
3.470
+0.400 (13.03%)
After-hours: Mar 28, 2024, 7:46 PM EDT

VYNE Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for VYNE Therapeutics stock have an average target of 7.38, with a low estimate of 5.75 and a high estimate of 9.00. The average target predicts an increase of 140.39% from the current stock price of 3.07.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $5.75 $7.38 $9.00 $9.00
Change +87.30% +140.39% +193.16% +193.16%

Analyst Ratings

The average analyst rating for VYNE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 111111
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.75
Strong Buy Reiterates $5.75 +87.30% Feb 29, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$28$5.75
Strong Buy Maintains $28$5.75 +87.30% Oct 30, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$28
Strong Buy Reiterates $28 +812.05% Aug 14, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$5$9
Buy Maintains $5$9 +193.16% May 12, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$28
Strong Buy Reiterates $28 +812.05% May 12, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
459.00K
from 424.00K
Increased by 8.25%
Revenue Next Year
255.00K
from 459.00K
Decreased by -44.44%
EPS This Year
-1.02
from -2.78
EPS Next Year
-0.98
from -1.02
Year 2019202020212022202320242025202620272028
Revenue
443.00K20.99M931.00K477.00K424.00K459.00K255.00K255.00K10.46M58.19M
Revenue Growth
-87.68%4,638.83%-95.57%-48.76%-11.11%8.25%-44.44%-4,000.00%456.59%
EPS
-201.96-141.84-25.64-7.28-2.78-1.02-0.98-1.07-9.95-0.15
EPS Growth
----------
No. Analysts -----44433
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 525,000 525,000 525,000 21.5M 105.5M
Avg 459,000 255,000 255,000 10.5M 58.2M
Low 392,000 n/a n/a n/a 13.3M

Revenue Growth

Revenue Growth 20242025202620272028
High
23.8%
14.4%
105.9%
8,341.2%
909.4%
Avg
8.3%
-44.4%
-
4,000.0%
456.6%
Low
-7.5%
- - -
27.5%

EPS Forecast

EPS 20242025202620272028
High -1.05 -1.01 -1.10 -10.24 -0.16
Avg -1.02 -0.98 -1.07 -9.95 -0.15
Low -0.98 -0.94 -1.03 -9.56 -0.15

EPS Growth

EPS Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.